Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pan-RAS-IN-1
Cat. No.:
OB0225LY-0064
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Pan-RAS-IN-1 is a small molecule inhibitor that specifically targets RAS family proteins such as K-RAS, N-RAS and H-RAS. This molecule affects the activity of downstream signaling pathways by binding to specific sites on RAS proteins and inhibiting their activity.
Synonym:
1835283-94-7; 4-Amino-N-(3-(5-((4-(2,6-dichlorobenzyl)piperazin-1-yl)methyl)-3-(4-(trifluoromethoxy)phenyl)-1H-indol-1-yl)propyl)piperidine-4-carboxamide; 4-Amino-N-[3-[5-[[4-[(2,6-dichlorophenyl)methyl]piperazin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]propyl]piperidine-4-carboxamide; 4-Amino-N-{3-[5-({4-[(2,6-dichlorophenyl)methyl]piperazin-1-yl}methyl)-3-[4-(trifluoromethoxy)phenyl]indol-1-yl]propyl}piperidine-4-carboxamide
CAS No.:
1835283-94-7
Compound CID:
102004330
Formula:
C36H41Cl2F3N6O2
Formula Weight:
717.65
Specification
Relative Density:
1.38 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pan-RAS-IN-1 can be used to disrupt the interaction between Ras proteins and their effectors.
Library Information
Targets:
MAPK; Ras
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 69.67 mM
